Cirrhotic cardiomyopathy (CCM) is a significant complication of cirrhosis, but its progression and underlying mechanisms ...

Bristol Myers Squibb today announced positive topline results from SCOUT-HCM, a Phase 3 trial evaluating Camzyos (mavacamten) ...

The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Myqorzo is a cardiac myosin ...

MYQORZO is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is contraindicated with ...

Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at University of Michigan, according to a recent study. Researchers trained the ...

aBritish Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine, Faculty of Life Science, King's College London, London, UK Heart failure is a complex clinical syndrome ...

Chris has reported for various tech and consumer goods outlets over the past decade, including Android Police and MakeUseOf since early 2022. Previously, he has contributed to outlets such as ...

Samsung is breaking new ground with a world-first innovation: the integration of detection and monitoring of Left Ventricular Systolic Dysfunction (LVSD) into its smartwatches. LVSD is a serious ...

Samsung is working on ways to detect Left Ventricular Systolic Dysfunction (LVSD) using the Galaxy Watch. It has also conducted trials and received approval from South Korea’s Ministry of Food and ...

Panel A shows a cross-section of a normal heart (top) and an endomyocardial biopsy sample from a normal heart (bottom; with hematoxylin and eosin staining) that shows normal histologic characteristics ...